Skip to content
EmbarkNeuro
About
About Us
Our Team
Board of Directors
Scientific Advisors
Our Science
Rooted in Biology
Publications & Presentations
Clinical Trials
News
Careers
Contact
Our Science
Publications & Presentations
September 19, 2022
ANC 501: A Novel V1b Receptor Antagonist for Major Depressive Disorder
May 1, 2021
Prediction of a clinically effective dose of THY1773, a novel V1B receptor antagonist, based on preclinical data
May 1, 2021
Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study
